GN Store Nord A/S (OTCMKTS:GNNDY – Get Rating) was upgraded by stock analysts at Jefferies Financial Group from an “underperform” rating to a “hold” rating in a research report issued on Wednesday, The Fly reports.
A number of other equities analysts have also issued reports on GNNDY. Credit Suisse Group raised shares of GN Store Nord A/S from a “neutral” rating to an “outperform” rating in a research report on Tuesday, October 18th. Citigroup started coverage on shares of GN Store Nord A/S in a research note on Monday, December 12th. They set a “buy” rating on the stock. JPMorgan Chase & Co. dropped their price objective on shares of GN Store Nord A/S from 344.00 to 208.00 in a research note on Monday, November 7th. Finally, Morgan Stanley started coverage on shares of GN Store Nord A/S in a research note on Tuesday, October 18th. They set an “equal weight” rating on the stock. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, GN Store Nord A/S has an average rating of “Moderate Buy” and a consensus target price of $236.50.
GN Store Nord A/S Stock Performance
Shares of GN Store Nord A/S stock opened at $75.70 on Wednesday. The firm has a market capitalization of $3.46 billion, a P/E ratio of 32.35 and a beta of 1.05. The company has a quick ratio of 0.52, a current ratio of 0.87 and a debt-to-equity ratio of 1.49. The company has a 50 day moving average price of $71.13 and a 200 day moving average price of $77.13. GN Store Nord A/S has a 52 week low of $46.88 and a 52 week high of $187.35.
GN Store Nord A/S Company Profile
GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer technology solutions in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products.
- Get a free copy of the StockNews.com research report on GN Store Nord A/S (GNNDY)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Receive News & Ratings for GN Store Nord A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GN Store Nord A/S and related companies with MarketBeat.com's FREE daily email newsletter.